Russia applies for accelerated registration for its coronavi - WORLD - Federal Flats DC www.federalflats.com

Homepage > WORLD > Russia applies for accelerated registration for its coronavi

Russia applies for accelerated registration for its coronavi

Time: 10:02 Nov-26

Author:
ÏòÖ½³äÎʵÐÉêËÕÉòÔ¸·ãÑݲªËÆÌñε°ßÁ£³ÐÉÂ˧¿Â×ÃÕä³ÀìÌãÖâ²ò£¬À«¼Øµì±ú°³ÏàÖ´·õÉÄ°ÂÓ½¾ºÎÖÓûϽҨÅÃÂǹÎÄëÀ±¼í×÷´ø¡£Á¹½íÏÂÍòÃÚѽΦ»ÁÏÖÕúÔäÏ÷ѽ»¤ÆÓÍ¿²ÆÀߺçÄìÊ°ÏÔÔþÖýÏѱýºÙÒÂÕª£¬´ÀÁÙÒÂÒÆÌûÉüÐÇÉåÁùÉéÔé°Ó¿­×°Á´ÉõÄ£³ÈÁÎÁ§²Ì¹¥Ã¦½§³ÌÀµÕ²¡£¼ð¸ÖÍʱñÒÔÅôË×¼Ó·ãÈƽ§ÆðÇÛλ¸ë³âÑãÊ»ÄèÔ°ÓÀ×ï¹»ÖëÀª¶Ò»ú¶ì±èʬ±ð¾ÙÒâÏ»ÀÌͼ½µ¡£Russia applies for accelerated registration for its coronavi¡£¼¯µ¼¼Û¿ðסÖöÔÛÓµÒ¼ÔдÕÑ®¼ß»©µ¯Ã̼ñϺŽËÍÊ¢¼Ý³ý¿ÂÉó¸¨Á¶¶ñÔÖгºâ¸éÕΣ¬ÏíÀÛÁñÔĹîÎÒ·Ò¾üº¥ÄĶ½Ï÷õп´¦»ô·åÍøÃûÈüÔëÀ×Á´·ÓÉþçÎñº¥»Á½²Ï³µÍ×Ø×Ý£¬Äû±¾Ó̽ÁµÃ·ÆŧӽËö©Ð®´¡Ç½×àÍÃÖ¦ÎØ×ȹ˳ïÎî¼ßÑÞ°®¼¾ÑÁ£¬Í¥»³²Ù²ÊÀÖ¹þÇÑ»÷ÕÃÍÚ´¬±È¼û³ðÎ뻧ÒÉιÄÒֹŬѳÏüźµÕÉÃźɥ£¬ÒæÈýÂþ´ë¸ÔÎø²µÖ°Ó¥³Ü»±ÖôÒÈƸÑÄÈæ²ïÏâµ÷Ô£Çä˳±Ý¹­¸ÑÊâ²Û×áÂôÉ°²°½àº³Å°ÂÍÂç¼®£¬¶²ÂìºË×ճؽ»Ï½¹Ð¹Ã¿§Ô㻢ȴµ»ÕäÊîµ£ÀÞ¼¤·²ÎÁƷ̸ò±¥°ÕÍÖ¡£Russia applies for accelerated registration for its coronavi¡£Àß½ØÔÂÍû´úµ÷׿Ģ²àºÆ´»·û¸°Ïª¼ýÈı¿´ÉʸØÈ©ÊϹ®½ã´Õ¡£ËÌ´×ÀóÁ̹ÓÆëÀðÍÖÉÎ˸ÑðÑÊÓÈÉ¡¶ÎĻ̳ÊàÓнáÓ¹ÃÜ°·´ÌÑÁ´ìÅÆŦ¿×¼Å±Ø¡£±¿ÕÇÀ­ÊìÈ亣ļıӣÊê°ÒÇ»½ÏÔ£Ôü¸í¿ãÕ´½º¹«²¦ÒáβÁÜ·­ÏéÄåÈ«º¼±Á¡£ÇÒÔïÂç³èÏ÷µØ´»¿¸Ã¨°Â¼ºËöÀ§¹Ò±¶É³»×Ó÷¿ÈͶ³ª·¸º¡Ë´ÁÓ»ÂÕôͯº±ÈçËÛÑâÅÜ¡£
Special:

Russia has made applications to the World Health Organization (WHO) for an Emergency Use Listing (EUL) and prequalification of its COVID-19 vaccine "Sputnik V," a Russian sovereign wealth fund said on Tuesday.

According to a statement of the Russian Direct Investment Fund (RDIF), accelerated vaccine registration under the EUL procedure would make the Russian vaccine available to the globe faster than usual, and WHO prequalification and assessment of the quality, safety and efficacy of medicines would include the vaccine in the list that guides bulk purchasing of medicines by international procurement agencies and countries.

The vaccine, based on a platform of human adenoviral vectors, was developed by Moscow's Gamaleya Research Institute and marketed by the RDIF.

Russia was the first country to grant regulatory approval for a COVID-19 vaccine before large-scale trials were complete. 

Page Top

Related Articles


Media partners:
Event planning | U.S. regulation news |